Virtually every patient who walks through your door presents a contact lens opportunity - whether they are new to contact lenses, or an existing wearer you can upgrade to more comfortable, higher performance contact lenses.
To help you enhance your contact lens practice, we offer a full range of exceptional contact lenses, with something to fit virtually every patient, and every vision condition including:
And we back that up with policies like our Simply Satisfied patient guarantee program.
Prescribe the contact lens of confidence. Featuring Aquaform® Technology and delivering an exceptional overall 1-day experience.
Nearsighted or farsighted. Astigmatism or presbyopia. Get the healthy advantages of a silicone hydrogel 1-day contact lens.
Monthly replacement schedule. Lenses stay moist and comfortable. Naturally wettable so you're less likely to need additional wetting drops.
Two-week replacement silicone hydrogel lenses offering long-lasting comfort, high water content and Class 1 UV blocker* to your near-sighted, far-sighted and astigmatic patients.
The FIRST and ONLY FDA-approved** soft contact lens proven to slow the progression of myopia (nearsightedness) in children, aged 8-12 at the initiation of treatment.1†
*Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
**Indications for Use: MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
† Compared to a single vision 1 day lens over a 3 year period
1. Chamberlain P, et al. A 3-Year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. 2019;96(8):556-7. 2. Tideman JW, et al. Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia. JAMA Ophthalmol. 2016;134(12):1355-63.